Use of bacteriophages for control of escherichia coli O157
US6485902B2 · kind B2 · utility
26Cited by
6References
12Claims
0Family size
Inventors
Key dates
| Filing date | Jun 5, 2001 |
| Grant date | Nov 26, 2002 |
| Priority date | — |
| Expiry date | Jun 5, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2795/00051
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A method of reducing levels of E. coli O157 strains within the gastrointestinal tract of a ruminant animal using specific bacteriophage(s) is herein described. Also described is a pharmaceutical composition comprising at least one of said bacteriophages and a method for isolating or selecting bacteriophages useful in reducing E. coli O157 levels as described above.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.